CEVA vs OGN · P/E 244, rev $29.0M vs P/E 3.4, rev $6.40B
CEVA Inc (CEVA) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
CEVA Inc (CEVA) is a semiconductors company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CEVA revenue for 2026-06-30 was $29.0M. Net income was -$2.9M. Revenue was up 7.4% from 2026-03-31 to 2026-06-30. CEVA currently screens at market cap $525.7M and trailing P/E 244.2.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CEVA currently screens at market cap $525.7M and trailing P/E 244.2. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CEVA and OGN stock pages for the full models.
Not investment advice.